Welcome to our META:PHI blog, which aims to provide insight into the evolving issues of substance use and treatment in Ontario.

META:PHI is excited to be able to shine a light into the important matters that practitioners across Ontario face when caring for patients in RAAM clinics and other settings.

We hope that in sharing this information among our healthcare community, we can provide more sustainable direction and support for our patients as they move along their path to recovery.

We will discuss these topics with a lens into the implications these issues may have on direct practice and patient care.

We also welcome any suggestions for topics or issues related to substance use and treatment.

Limited Use Status for Acamprosate and Naltrexone

Aug 30, 2018

As of June 29, 2018, acamprosate and naltrexone can be prescribed under Limited Use Status in Ontario. Prescribers will no longer be required to obtain approval through the Exceptional Access Program.…

Tagged alcohol use disorder, implications for practice, MOHLTC, pharmacotherapy